MENU
CGEM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cullinan Therapeutics (CGEM) Ownership - Who owns Cullinan Therapeutics?

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer... Show more

Profile

Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
109
Web
https://www.cullinantherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
962.1M
P/E Ratio
8.37
Total Cash
334.54M
Projected Growth
N/A
Total Debt
2.07M
Revenue
N/A
Risk (Beta)
-0.21
Dividend Yield
N/A
Total Cash/Share
5.20
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns Cullinan Therapeutics? CGEM symbol Ownership - Tickeron.com